Skip to main content
. 2017 Aug 28;135(3):545–552. doi: 10.1007/s11060-017-2601-y

Fig. 4.

Fig. 4

QLQ-C30 Global Health Status and General Scales in TTFields/TMZ versus TMZ alone groups over 12 months in Per Protocol Population. EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30; SD standard deviation, TMZ temozolomide, QoL quality of life